登录

Valcadia Healthcare Partners宣布医药服务并购交易结束

Valcadia Healthcare Partners Announces Pharma Services M&A Transaction Closing

businesswire | 2024-05-03 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


DENVER--(BUSINESS WIRE)--Valcadia Healthcare Partners LLC (“Valcadia” or “VHP”), an independent healthcare investment bank established in 2023, announces the closing of its first completed mergers and acquisition engagement, in February 2024. The transaction target, which was not disclosed, operates an outsourced clinical research services business focused on Alzheimer’s disease and liver disease and is based in the Southeastern United States.

丹佛--(商业新闻短讯)--Valcadia Healthcare Partners LLC(“Valcadia”或“VHP”)是一家成立于2023年的独立医疗投资银行,宣布于2024年2月结束其首次完成的并购业务。未披露的交易目标公司在美国东南部经营一项外包临床研究服务业务,专注于阿尔茨海默氏病和肝病。

The acquirer is a private equity backed clinical research platform..

收购方是一个私人股本支持的临床研究平台。。

Valcadia is known for fierce and conflict-free representation of independent healthcare entrepreneurs and has an exclusive focus on the Health Sciences and Outsourced Pharmaceutical Services industry.

瓦尔卡迪亚以独立医疗企业家的激烈和无冲突代表而闻名,并专注于健康科学和外包制药服务行业。

GENERAL VHP BUSINESS UPDATE

一般VHP业务更新

Valcadia has multiple additional health sciences M&A engagements currently underway which are also expected to close this year. Given its backlog and pipeline, combined with an uptick in more favorable middle market healthcare transaction conditions, Valcadia is also pleased to report it anticipates excellent performance in 2024 as it ramps up for its first full-year of operations..

瓦尔卡迪亚目前正在进行多项额外的健康科学并购活动,预计今年也将结束。鉴于其积压和管道,再加上更有利的中等市场医疗保健交易条件的上升,瓦尔卡迪亚也很高兴地报告,随着其第一个全年的运营,预计2024年将取得优异的业绩。。

“Technology has flattened the playing field,” commented Ethan Goodson, Founder and Managing Partner of VHP, “and as a result increasing numbers of savvy healthcare and life sciences entrepreneurs are choosing investment banks with a more intentional approach, with the requisite experience, but unburdened by the suffocating bureaucracy larger financial institutions are often known for.”.

VHP创始人兼管理合伙人伊桑·古德森(EthanGoodson)评论道:“技术已经使竞争环境变得平坦,因此,越来越多精明的医疗保健和生命科学企业家正在选择投资银行,他们选择的方法更具目的性,拥有必要的经验,但不受令人窒息的官僚作风的影响。大型金融机构往往以其著称。”。

“We are immensely grateful for the support and confidence of our initial cohort of clients, whom we view as true partners,” continued Ethan Goodson, “and we take the obligation that accompanies that trust and confidence incredibly seriously.”

伊桑·古德森(EthanGoodson)继续说道:“我们非常感谢我们最初的客户群的支持和信心,我们认为他们是真正的合作伙伴,我们非常认真地对待伴随着这种信任和信心的义务。”

Please visit www.valcadiahealthcarepartners.com for updates and additional information.

请访问www.valcadiahealthcarepartners.com以获取更新和其他信息。

推荐阅读

Honda电控离合器技术于北京摩展发布,新车型、新技术、新乐趣,一起“新心共振”

本田 2024-05-17 18:57

康龙化成拟出售对Proteologix投资的股权预计收到约8682.1万美元的首期付款

智通财经 2024-05-17 18:44

Brainomix的肺部疾病成像AI获得美国食品药品监督管理局批准

pharmaphorum 2024-05-17 18:35

businesswire

6556篇

最近内容 查看更多

医疗保健服务提供商NADclinic和邦泰克生物工程宣布建立战略合作伙伴关系,通过NAD+的力量推动全球健康事业的未来发展

5 小时后

Drug Farm宣布美国食品药品监督管理局批准IND,使ROSAH综合征患者能够启动ALPK1选择性激酶抑制剂DF-003的1b期启动

4 小时后

Cleveland Bakers and Teamsters健康与福利基金与Curio Digital Therapeutics合作,为会员提供革命性的孕产妇心理健康支持

8 小时前

产业链接查看更多